Novo Nordisk A/S (NVO)
37.22
+0.24
(+0.65%)
USD |
NYSE |
Apr 06, 09:37
Novo Nordisk Market Cap : 167.46B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 30.41M |
| Ascendis Pharma A/S | 14.18B |
| Viking Therapeutics, Inc. | 4.234B |
| DBV Technologies SA | 1.186B |
| Cellectis SA | 337.94M |
Market Cap Related Metrics
| PE Ratio | 10.73 |
| PS Ratio | 3.544 |
| PEG Ratio | 1.900 |
| Price to Book Value | 7.141 |
| Price to Free Cash Flow | 37.64 |
| Price | 37.22 |
| Earnings Yield | 9.32% |
| PEGY Ratio | 1.020 |
| Operating PE Ratio | 8.608 |
| Normalized PE Ratio | 10.73 |